Advantis Corp. | Income Statement

Fiscal year is January-December. All values USD Thousands.
2014
2015
2016
2017
2018
Sales/Revenue
32.00
36.80
46.30
406.20
827
Cost of Goods Sold (COGS) incl. D&A
32.00
21.80
19.40
113.50
64.10
Gross Income
-
15.00
26.90
292.70
762.90
SG&A Expense
62.60
253.00
243.50
401.90
784.60
EBIT
81.80
239.90
217.40
113.10
23
Unusual Expense
-
348.50
110.00
-
-
Interest Expense
0.20
0.10
0.40
0.60
0.70
Pretax Income
81.90
108.60
106.10
113.70
23.60
Consolidated Net Income
81.90
108.60
106.10
113.70
23.60
Net Income
81.90
108.60
106.10
113.70
23.60
Net Income After Extraordinaries
81.90
108.60
106.10
113.70
23.60
Net Income Available to Common
81.90
108.60
106.10
113.70
23.60
EPS (Basic)
0.00
0.00
0.00
0.00
-
Basic Shares Outstanding
708,193.90
708,193.90
918,969.70
978,465.90
978,465.90
EPS (Diluted)
0.00
0.00
0.00
0.00
-
Diluted Shares Outstanding
708,193.90
708,193.90
918,969.70
978,465.90
978,465.90
EBITDA
81.80
239.90
217.40
113.10
23
Other Operating Expense
19.20
1.90
0.90
3.90
1.30
Equity in Affiliates (Pretax)
-
-
1.70
-
-

About Advantis

View Profile
Address
1048 Irvine Boulevard
Newport Beach California 92660
United States
Employees -
Website http://www.advantiscorp.com
Updated 07/08/2019
Advantis Corp. engages in the provision of healthcare products and holistic pain management solutions. Its products is comprised of amster-can premium vapes, gino's roasters, hemperor's club premium vapes, rosin6 rosin press, n2pack and natural elements. The firm focuses on products that supply the medical cannabis, research, and pharmaceutical industries.